Belluscura shares dive as withdraws market guidance amid US tariffs

Related news

Belluscura PLC on Tuesday withdrew its previous financial guidance for 2025, citing to the US imposition of tariffs on imports.

The London-based medical device developer highlighted that a ‘significant proportion’ of its portable oxygen concentrators, raw materials and component parts are made in China. They are facing a 54% tariff when imported to the US.

The firm expects to make a further announcement once it has been able to better assess the situation.

Belluscura shares were down 44% to 0.70 pence each on Tuesday morning in London.

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Trading statements

Ways to help you invest your money

Our investment accounts

Put your money to work with our range of investment accounts. Choose from ISAs, pensions, and more.

Need some investment ideas?

Let us give you a hand choosing investments. From managed funds to favourite picks, we’re here to help.

Read our expert tips and insights

Our investment experts share their knowledge on how to keep your money working hard across the markets.